InMode Ltd.

NASDAQ:INMD

Medical - Devices

Healthcare
$12.88 +0.26%

+$0.04 today

Market cap
$741.17M
Beta
1.93
P/E (TTM)
9.7
EPS (TTM)
$1.38
52W Low $12.72High $16.74

Volume 0.31M

Average 0.85M

INMD Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

InMode Ltd.NASDAQ: INMD

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation outflow shrinks to $0

Q1 FY2026 stock-based compensation was $0, compared with $2.52M a year earlier. Trailing-twelve-month stock-based compensation was $2.5M. Over 3 fiscal years it compounded at -23.1% a year.

Context

  • Stock-based compensation amounted to 3.0% of revenue in FY2025, down 1.2 pp from a year earlier.
  • Stock-based compensation increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $624.75K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$11.13M-32.8% YoY
LTMMar 2026
$2.5M-77.5% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-32.8%——
3-year CAGR-23.1%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
11.13M USD
Year-over-year change
-32.8%
4-year CAGR
-1.8%

Stock-Based Compensation vs competitors

How INMD compares with its peers on the latest reported figures

  • INMD's LTM Mar 2026 stock-based compensation of $2.5M is the smallest of the 5 companies compared; the peer median is $10.02M.
  • Its year-over-year change of -77.5% is the lowest of 5, against a peer median of -37.3%.
  • Stock-based compensation amounts to 0.7% of revenue for INMD, versus a peer median of 4.4%.
INMD Competitors Peer median
Stock-Based Compensation for INMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALGNAlign Technology, Inc.LTM Jun 2026$185.87M +111.5%+11.7%4.5%
SKINThe Beauty Health CompanyLTM Mar 2026$13.43M -43.0%-19.6%4.5%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$6.61M -43.9%-57.1%4.4%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$6.28M -31.7%—2.4%
INMDInMode Ltd.LTM Mar 2026$2.5M -77.5%-23.1%0.7%
Peer median (excluding INMD) $10.02M-37.3%-19.6%4.4%

Competitors are the stored peer set for INMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income165.07M161.52M197.92M181.28M93.83M
Depreciation & Amortization517K680K623K728K695K
Deferred Income Tax(770K)84K(184K)(55.18M)2.93M
Stock-Based Compensation11.96M24.45M23.6M16.57M11.13M
Change in Working Capital(3.81M)(4.47M)(41.44M)(7.07M)(24.3M)
Accounts Receivables(10.54M)(10.42M)(18.31M)251K(11.13M)
Inventory(6.04M)(18.87M)(5.2M)(14.45M)(14.5M)
Accounts Payables2.37M7.46M(2.28M)(184K)4.13M
Other Working Capital10.41M17.36M(15.66M)7.32M(2.79M)
Other Non-Cash Items1.91M(690K)(3.69M)(3.66M)967K
Operating Cash Flow174.89M181.58M176.83M132.66M85.26M
Capital Expenditures(939K)(1.58M)(705K)(669K)(972K)
Acquisitions (Net)3.91M20.61M000
Purchases of Investments(346.92M)(262.38M)(478.68M)(504.41M)(313.51M)
Sales of Investments187.76M154.48M343.32M667.28M500.52M
Other Investing Activities(3.91M)(20.61M)000
Investing Cash Flow(160.11M)(109.47M)(136.06M)162.21M186.03M
Debt Repayment00000
Common Stock Issued005.5M01.39M
Common Stock Repurchased(35.37M)(42.64M)0(285.39M)(127.44M)
Dividends Paid00000
Other Financing Activities01.55M02.61M0
Financing Cash Flow(15.02M)(41.09M)5.5M(282.77M)(126.06M)
Effect of Forex Changes(559K)(1.62M)605K(1.18M)1.98M
Net Change in Cash(802K)29.4M46.87M10.92M147.21M
Free Cash Flow173.95M180M176.12M132M84.29M

InMode Ltd.

NASDAQ:INMD

Intrinsic Alpha fair value

Locked

Current Price

$12.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.